"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 10 | 2 | 12 |
| 1995 | 9 | 1 | 10 |
| 1996 | 22 | 14 | 36 |
| 1997 | 25 | 15 | 40 |
| 1998 | 36 | 12 | 48 |
| 1999 | 28 | 18 | 46 |
| 2000 | 14 | 12 | 26 |
| 2001 | 19 | 13 | 32 |
| 2002 | 8 | 5 | 13 |
| 2003 | 18 | 7 | 25 |
| 2004 | 13 | 15 | 28 |
| 2005 | 14 | 10 | 24 |
| 2006 | 19 | 13 | 32 |
| 2007 | 9 | 10 | 19 |
| 2008 | 8 | 13 | 21 |
| 2009 | 12 | 10 | 22 |
| 2010 | 13 | 12 | 25 |
| 2011 | 11 | 8 | 19 |
| 2012 | 12 | 10 | 22 |
| 2013 | 17 | 14 | 31 |
| 2014 | 18 | 9 | 27 |
| 2015 | 4 | 12 | 16 |
| 2016 | 13 | 9 | 22 |
| 2017 | 10 | 6 | 16 |
| 2018 | 8 | 6 | 14 |
| 2019 | 8 | 11 | 19 |
| 2020 | 7 | 10 | 17 |
| 2021 | 6 | 6 | 12 |
| 2022 | 1 | 7 | 8 |
| 2023 | 1 | 9 | 10 |
| 2024 | 1 | 6 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Chromoblastomycosis: A Potential Mimic of Squamous Cell Carcinoma in Transplant Recipients. Transplant Proc. 2024 Jul-Aug; 56(6):1454-1456.
-
Mystery lung mass in a kidney transplant recipient. Transpl Infect Dis. 2024 Aug; 26(4):e14353.
-
Clinical associations with a polygenic predisposition to benign lower white blood cell counts. Nat Commun. 2024 Apr 22; 15(1):3384.
-
Ocular Mucous Membrane Pemphigoid: The Effect of Risk Factors at Presentation on Treatment Outcomes. Ophthalmology. 2024 Sep; 131(9):1064-1075.
-
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
-
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 01 15; 209(2):137-152.
-
Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay? Am J Clin Pathol. 2024 Jan 04; 161(1):97-106.
-
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).
-
Impact of Renal Replacement Therapy on Rejection among Liver Transplant Recipients. Prog Transplant. 2023 Dec; 33(4):348-355.
-
Elevated tacrolimus levels among COVID-19 kidney transplant recipients are associated with worse disease severity and clinical outcomes. Clin Nephrol. 2023 Nov; 100(5):216-223.